| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 130, 431-435, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
T Gansler, KD Allen, CF Burant, T Inabnett, A Scott, MG Buse, DA Sens and AJ Garvin
Department of Pathology, Medical University of South Carolina, Charleston 29425.
Insulinlike growth factors (IGFs) are peptide hormones that regulate proliferation and differentiation of several types of normal and neoplastic cells. Recent studies of Wilms' tumor, a childhood kidney neoplasm, have detected increased expression of IGF-2 mRNA and protein. The present report describes detection of Type 1 IGF receptors in specimens of Wilms' tumor and adjacent nonneoplastic kidney tissue. These receptors recognize both IGF-1 and IGF-2, and binding of either peptide activates endogenous tyrosine kinase activity of the Type 1 IGF receptor beta subunit. These data indicate that Wilms' tumors contain receptors that recognize and respond to exogenous IGF in vitro, and that autocrine IGF production might contribute to the increased proliferation and abnormal differentiation of these cells in vivo.
This article has been cited by other articles:
![]() |
R. Natrajan, J. S. Reis-Filho, S. E. Little, B. Messahel, M.-A. Brundler, J. S. Dome, P. E. Grundy, G. M. Vujanic, K. Pritchard-Jones, and C. Jones Blastemal Expression of Type I Insulin-Like Growth Factor Receptor in Wilms' Tumors Is Driven by Increased Copy Number and Correlates with Relapse Cancer Res., December 1, 2006; 66(23): 11148 - 11155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Trojan, T. Johnson, S. Rudin, J Ilan, M. Tykocinski, and J Ilan Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA Science, January 1, 1993; 259(5091): 94 - 97. [Abstract] [PDF] |
||||
![]() |
I. Drummond, S. Madden, P Rohwer-Nutter, G. Bell, V. Sukhatme, and F. Rauscher 3rd Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1 Science, July 31, 1992; 257(5070): 674 - 678. [Abstract] [PDF] |
||||
![]() |
T Glaser, J Lane, and D Housman A mouse model of the aniridia-Wilms tumor deletion syndrome Science, November 9, 1990; 250(4982): 823 - 827. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |